Partially Reversible Bilateral Papilledema in a Patient Using Anastrozole: A Case Study

Anastrozole is an endocrine-modifying agent used in the treatment of estrogen-sensitive breast cancer in the postmenopausal breast cancer population. Anastrozole is known for its side effect profile which includes an increased risk of osteoporosis. However, emerging evidence in the literature in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wortsman, Joshua, Proskuriakova, Ekaterina, Aryal, Barun, Khan, Sarah, Sanchez, Danielle, Anthony, Kyle, Khosla, Pam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685060/
https://www.ncbi.nlm.nih.gov/pubmed/38034139
http://dx.doi.org/10.7759/cureus.47925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685060/
https://www.ncbi.nlm.nih.gov/pubmed/38034139
http://dx.doi.org/10.7759/cureus.47925

Ejemplares similares